Eldecalcitol; Edirol; ED-71; 104121-92-8; 2-(3-Hydroxypropoxy)-1,25-dihydroxyvitamin D3; I2JP8UE90H; (1R,2R,3R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-2-(3-hydroxypropoxy)-4-methylidenecyclohexane-1,3-diol; 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3; ED 71; (5Z,7E)-(1R,2R,3R)-2-(3-hydroxypropoxy)-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol; 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)cholecalciferol; (1r,2r,3r,5z,7e,14beta,17alpha)-2-(3-Hydroxypropoxy)-9,10-Secocholesta-5,7,10-Triene-1,3,25-Triol; 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 / 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)cholecalciferol; Eldecalcitol [INN]; 2-(3-Hydroxypropoxy)calcitriol; Eldecalcitol [INN:JAN]; UNII-I2JP8UE90H; HY-A0020; Edirol (TN); Eldecalcitol (JAN/INN); ELDECALCITOL [MI]; ELDECALCITOL [JAN]; ELDECALCITOL [MART.]; ELDECALCITOL [WHO-DD]; GTPL2783; SCHEMBL5457151; CHEMBL4297608; CHEBI:73927; 2beta-(3-hydroxypropoxy)calcitriol; (1S,2S,3S,Z)-5-((E)-2-((1R,7AR)-1-((R)-6-HYDROXY-6-METHYLHEPTAN-2-YL)-7A-METHYLHEXAHYDRO-1H-INDEN-4(2H)-YLIDENE)ETHYLIDENE)-2-(3-HYDROXYPROPOXY)-4-METHYLENECYCLOHEXANE-1,3-DIOL; ELDECALCITOL; EX-A5554; ZINC3934328; CT-081; LMST03020477; AKOS025312299; CS-0363; DB05295; 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, 2-(3-hydroxypropoxy)-, (1alpha,2beta,3beta,5Z,7E)-; AC-26354; D07578; 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)-cholecalciferol; (1R,2R,3R,5Z,7E)-2-(3-hydroxypropoxy)-9,10-secocholesta-5,7,10-triene-1,3,25-triol; (5Z,7E)-2.BETA.-(3-HYDROXYPROPOXY)-9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1.ALPHA.,3.BETA.,25-TRIOL; ED9